View in EDS

Survey of current practices and opinions of German Society of Gynecologic Endoscopy members regarding the treatment of ovarian neoplasia by robotic surgery

Saved in:
Bibliographic Details
Title: Survey of current practices and opinions of German Society of Gynecologic Endoscopy members regarding the treatment of ovarian neoplasia by robotic surgery
Authors: J. S. M. Zimmermann, J. C. Radosa, M. P. Radosa, P. Sklavounos, P. A. Schweitzer, E. F. Solomayer
Source: Arch Gynecol Obstet
Publisher Information: Springer Science and Business Media LLC, 2020.
Publication Year: 2020
Subject Terms: Adult, Ovarian Neoplasms, 2. Zero hunger, ddc:610, Borderline ovarian tumor, Endoscopy, Robotic surgery, Gynecologic Oncology, Middle Aged, 3. Good health, Gynecologic Surgical Procedures, AGE, Robotic Surgical Procedures, Minimally invasive surgery, Ovarian cancer, Germany, Surveys and Questionnaires, Humans, Female, Prospective Studies, Societies, Surveys and Questionnaires [MeSH], Female [MeSH], Adult [MeSH], Humans [MeSH], Prospective Studies [MeSH], Endoscopy/methods [MeSH], Ovarian Neoplasms/surgery [MeSH], Middle Aged [MeSH], Gynecologic Surgical Procedures/methods [MeSH], Germany [MeSH], Societies [MeSH], Robotic Surgical Procedures/methods [MeSH], Ovarian Neoplasms/pathology [MeSH]
Description: Purpose As data on this topic are sparse and contradictory, we aimed to ascertain the opinions of the members of the German Society of Gynecologic Endoscopy (AGE) regarding the use of robotic surgery in the treatment of ovarian malignancies. Methods In 2015, an anonymous questionnaire was sent to AGE members to assess their views on the treatment of ovarian malignancies by robotic surgery according to T stage and the current treatment practices in their facilities. Results Of the 228 respondents, 132 (58%) were fellows or attending physicians and 156 (68%) worked at university hospitals or tertiary referral centers. Most [n = 218 (96%)] respondents reported treating Conclusion The majority of AGE members surveyed considered robotic surgery to be an option for the treatment of T1 ovarian malignancies and borderline ovarian tumors. However, prospective randomized studies are needed to determine the relevance of robotic surgery in this context.
Document Type: Article
Other literature type
Language: English
ISSN: 1432-0711
0932-0067
DOI: 10.1007/s00404-020-05876-w
DOI: 10.22028/d291-34550
Access URL: https://link.springer.com/content/pdf/10.1007/s00404-020-05876-w.pdf
https://pubmed.ncbi.nlm.nih.gov/33201376
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286217
https://publikationen.sulb.uni-saarland.de/bitstream/20.500.11880/31635/1/Zimmermann2021_Article_SurveyOfCurrentPracticesAndOpi.pdf
https://europepmc.org/article/MED/33201376
https://link.springer.com/article/10.1007/s00404-020-05876-w
https://link.springer.com/content/pdf/10.1007/s00404-020-05876-w.pdf
https://publikationen.sulb.uni-saarland.de/handle/20.500.11880/31635
https://repository.publisso.de/resource/frl:6466192
Rights: CC BY
URL: http://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (http://creativecommons.org/licenses/by/4.0/) .
Accession Number: edsair.doi.dedup.....4e74dd4f9b9fd8a880d4ff454a50b90c
Database: OpenAIRE
Description
Abstract:Purpose As data on this topic are sparse and contradictory, we aimed to ascertain the opinions of the members of the German Society of Gynecologic Endoscopy (AGE) regarding the use of robotic surgery in the treatment of ovarian malignancies. Methods In 2015, an anonymous questionnaire was sent to AGE members to assess their views on the treatment of ovarian malignancies by robotic surgery according to T stage and the current treatment practices in their facilities. Results Of the 228 respondents, 132 (58%) were fellows or attending physicians and 156 (68%) worked at university hospitals or tertiary referral centers. Most [n = 218 (96%)] respondents reported treating Conclusion The majority of AGE members surveyed considered robotic surgery to be an option for the treatment of T1 ovarian malignancies and borderline ovarian tumors. However, prospective randomized studies are needed to determine the relevance of robotic surgery in this context.
ISSN:14320711
09320067
DOI:10.1007/s00404-020-05876-w